Bacterial-binding dressings in the management of wound healing and infection prevention

a narrative review

Paul Chadwick, Karen Ousey

Research output: Contribution to journalReview article

Abstract

The aim of this review was to present the clinical data on the use of the family of bacterial-binding dressings (Sorbact; dialkylcarbamoyl chloride-coated) in the treatment of a variety of acute and chronic wounds. The findings are discussed in terms of the effectiveness of the bacterial-binding dressings on bacterial bioburden reduction, infection prevention, initiation/progression of wound healing and cost-effectiveness. The evidence in support of the bacterial-binding dressings is strongest in the area of infection prevention in surgical wounds, with several controlled trials showing the prophylactic benefit of the dressing in these wounds. Wound bioburden management in chronic wounds is supported by a number of clinical studies. In total, 29 published clinical studies (with a total of 4044 patients) were included in this review.
Original languageEnglish
Pages (from-to)370-382
Number of pages11
JournalJournal of wound care
Volume28
Issue number6
DOIs
Publication statusPublished - 2 Jun 2019

Fingerprint

Wound Infection
Bandages
Wound Healing
Wounds and Injuries
Infection
Cost-Benefit Analysis
Chlorides
Clinical Studies
Therapeutics

Cite this

@article{ebfb9bdff8e34896ad4cd24f52e2add3,
title = "Bacterial-binding dressings in the management of wound healing and infection prevention: a narrative review",
abstract = "The aim of this review was to present the clinical data on the use of the family of bacterial-binding dressings (Sorbact; dialkylcarbamoyl chloride-coated) in the treatment of a variety of acute and chronic wounds. The findings are discussed in terms of the effectiveness of the bacterial-binding dressings on bacterial bioburden reduction, infection prevention, initiation/progression of wound healing and cost-effectiveness. The evidence in support of the bacterial-binding dressings is strongest in the area of infection prevention in surgical wounds, with several controlled trials showing the prophylactic benefit of the dressing in these wounds. Wound bioburden management in chronic wounds is supported by a number of clinical studies. In total, 29 published clinical studies (with a total of 4044 patients) were included in this review.",
keywords = "bacterial bioburden, chronic wound, dialkylcarbamoyl chloride (DACC), infection, Sorbact, surgical site infection",
author = "Paul Chadwick and Karen Ousey",
year = "2019",
month = "6",
day = "2",
doi = "10.12968/jowc.2019.28.6.370",
language = "English",
volume = "28",
pages = "370--382",
journal = "Journal of wound care",
issn = "0969-0700",
publisher = "MA Healthcare Ltd",
number = "6",

}

Bacterial-binding dressings in the management of wound healing and infection prevention : a narrative review. / Chadwick, Paul; Ousey, Karen.

In: Journal of wound care, Vol. 28, No. 6, 02.06.2019, p. 370-382.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Bacterial-binding dressings in the management of wound healing and infection prevention

T2 - a narrative review

AU - Chadwick, Paul

AU - Ousey, Karen

PY - 2019/6/2

Y1 - 2019/6/2

N2 - The aim of this review was to present the clinical data on the use of the family of bacterial-binding dressings (Sorbact; dialkylcarbamoyl chloride-coated) in the treatment of a variety of acute and chronic wounds. The findings are discussed in terms of the effectiveness of the bacterial-binding dressings on bacterial bioburden reduction, infection prevention, initiation/progression of wound healing and cost-effectiveness. The evidence in support of the bacterial-binding dressings is strongest in the area of infection prevention in surgical wounds, with several controlled trials showing the prophylactic benefit of the dressing in these wounds. Wound bioburden management in chronic wounds is supported by a number of clinical studies. In total, 29 published clinical studies (with a total of 4044 patients) were included in this review.

AB - The aim of this review was to present the clinical data on the use of the family of bacterial-binding dressings (Sorbact; dialkylcarbamoyl chloride-coated) in the treatment of a variety of acute and chronic wounds. The findings are discussed in terms of the effectiveness of the bacterial-binding dressings on bacterial bioburden reduction, infection prevention, initiation/progression of wound healing and cost-effectiveness. The evidence in support of the bacterial-binding dressings is strongest in the area of infection prevention in surgical wounds, with several controlled trials showing the prophylactic benefit of the dressing in these wounds. Wound bioburden management in chronic wounds is supported by a number of clinical studies. In total, 29 published clinical studies (with a total of 4044 patients) were included in this review.

KW - bacterial bioburden

KW - chronic wound

KW - dialkylcarbamoyl chloride (DACC)

KW - infection

KW - Sorbact

KW - surgical site infection

UR - http://www.scopus.com/inward/record.url?scp=85066979145&partnerID=8YFLogxK

U2 - 10.12968/jowc.2019.28.6.370

DO - 10.12968/jowc.2019.28.6.370

M3 - Review article

VL - 28

SP - 370

EP - 382

JO - Journal of wound care

JF - Journal of wound care

SN - 0969-0700

IS - 6

ER -